Large damages payment looms for generic manufacturers in relation to Escitalopram

The Full Federal Court of Australia has dismissed an appeal by Alphapharm and others against the Federal Court decision to allow a patent term extension on Lundbeck’s patent covering the antidepressant drug Escitalopram (LEXAPRO) (the Escitalopram Patent) – Alphapharm Pty Ltd v H Lundbeck A/S [2015] FCAFC 138.   Background The patent at issue, Australian